Christophe Caux

Selected Publications

• A clinically relevant morpho-molecular classification of lung neuroendocrine tumours (2025) DOI
• Spatial tumour-immune ecosystems shape the efficacy of anti-PD1 immunotherapy in primary cutaneous melanoma (2025) DOI
• Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial (2025) DOI
• Data from The Spatial Organization of cDC1 with CD8<sup>+</sup> T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma (2025) DOI
• The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma (2025) DOI
• KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer (2024) DOI
• Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma (2024) DOI
• The Impact of TLR9 Expression Loss on Breast Cancer Tumor Cells (2024) DOI
• Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients (2024) DOI
• NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer (2024) DOI
• Spatial architecture of CD8 ⁺ T cells and DC subsets is critical for the response to immune checkpoint inhibitors in melanoma (2024) DOI
• The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers (2024) DOI
• La thérapie cellulaire dans tous ses états (2024) DOI
• MDR1-expressing CD4⁺ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response (2023) DOI
• Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes (2023) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics